AKT1 and breast carcinoma: EGFR overexpression is well-studied in breast cancer [28], and EGFR-driven signaling pathways such as PI3K/AKT/mTOR, JAK/STAT, and Ras/Raf/MAPK were associated with cell proliferation and survival [29].